Serum proteomic analysis from bacteremic and leucopenic rabbits

Journal of Surgical Research

Volumn 171, Issue 2, 2011, Pages 749-754

  Zhou, Zheng ^a   Ren, Jianan ^a   Liu, Haiyan ^b   Gu, Guosheng ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

bacteremia; leucopenia; serum proteomics; two dimensional gel electrophoresis

Indexed keywords

BIOLOGICAL MARKER; DESMIN; INTERLEUKIN 4; INTERLEUKIN 6; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; CONTROLLED STUDY; DISEASE MARKER; KLEBSIELLA PNEUMONIAE; LEUKOPENIA; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RABBIT; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; BACTEREMIA; BIOLOGICAL MARKERS; BLOOD PROTEINS; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LEUKOPENIA; PROTEOMICS; RABBITS; UP-REGULATION;

EID: 81155131456     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.04.056     Document Type: Article

References (34)

1. A.M. Sostarich, D. Zolldann, and H. Haefner Impact of multi-resistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay Infection 36 2008 31
2. S.E. Cosgrove, Y. Qi, and K.S. Kaye The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital sharges Infect Control Hosp Epidemiol 26 2005 166
3. R. Chang, and G.Y. Wong Prognostic significance of marked leukocytosis in hospitalized patients J Gen Inter Med 6 1991 199
4. L. Leibovici, M. Drucker, and Z. Samra Prognostic significance of the neutrophil count in immunocompetent patients with bacteremia QJM 88 1995 181
5. M. Venditti, M. Falcone, and S. Corrao Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia Ann Intern Med 150 2009 19
6. V.C. Wasinger, S.J. Cordwell, and A. Cerpa-Poljak Progress with gene-product mapping of the mollicutes: Mycoplasma genitalium Electrophoresis 16 1995 1090
7. R. Chen, S. Pan, and T.A. Brentnall Proteomic profiling of pancreatic cancer for biomarker discovery Mol Cell Proteomics 4 2005 523
8. E.F. Petricoin, A.M. Ardekani, and B.A. Hitt Use of proteomic patterns in serum to identify ovarian cancer Lancet 359 2002 572
9. T. Liu, W.J. Qian, and H.M. Mottaz Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry Mol Cell Proteomics 5 2006 2167
10. M.G. Price Molecular analysis of intermediate filament cytoskeleton - A putative load-bearing structure Am J Physiol 246 1984 H566
11. L.G. Goldfarb, K.Y. Park, and L. Cervenáková Missense mutations in desmin associated with familial cardiac and skeletal myopathy Nat Genet 19 1998 402
12. K.Y. Park, M.C. Dalakas, and H.H. Goebel Desmin splice variants causing cardiac and skeletal myopathy J Med Genet 37 2000 851
13. M.C. Dalakas, A. Dagvadorj, and B. Goudeau Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations Neuromuscul. Disord 13 2003 252
14. R. Schröder, B. Goudeau, and M.C. Simon On noxious desmin: Functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria Hum Mol Genet 12 2003 657
15. D. Li, T. Tapscoft, and O. Gonzalez Desmin mutation responsible for idiopathic dilated cardiomyopathy Circulation 100 1999 461
16. A. Ariza, and J.J. Navaspalacios Desmin myopathy: A multisystem disorder involving skeletal, cardiac, and smooth muscle Hum Pathol 26 1995 1032
17. A.M. Muñoz-Mármol, G. Strasser, and M. Isamat A dysfunctional desmin mutation in a patient with severe generalized myopathy Proc Natl Acad Sci USA 95 1998 11312
18. D.N. Sheppard, and M.J. Welsh Structure and function of the CFTR chloride channel Physiol Rev 79 1999 S23
19. S.M. Travis, B.A. Conway, and J. Zabner Activity of abundant antimicrobials of the human airway Am J Respir Cell Mol Biol 20 1999 872
20. R. Bals, D.J. Weiner, and A.D. Moscioni Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide Infect Immun 67 1999 6084
21. J.B. Goldberg, and G.B. Pier The role of the CFTR in susceptibility to Pseudomonas aeruginosa infections in cystic fibrosis Trends Microbiol 8 2000 514
22. G.B. Pier Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections Proc Natl Acad Sci USA 97 2000 8822
23. T.H. Schroeder, N. Reiniger, and G. Meluleni Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract J Immunol 166 2001 7410
24. R.G. Painter, R.W. Bonvillain, and V.G. Valentine The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils J Leukocyte Biol 83 2008 1345
25. J. Wan, W. Sun, and X. Li Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase Proteomics 6 2006 2886
26. M. Mori, S.C. Morris, and T. Orekhova IL-4 promotes the migration of circulating B cells to the spleen and increases splenic B cell survival J Immunol 164 2000 5704
27. S.C. Morris, W.C. Gause, and F.D. Finkelman IL-4 suppression of in vivo T cell activation and antibody production J Immunol 164 2000 1734
28. K.J. Erb, B. Rüger, and M. von Brevern Constitutive expression of interleukin-4 (IL-4) in vivo causes autoimmune-type disorders in mice J Exp Med 185 1997 329
29. R.R. Singh IL-4 and many roads to lupuslike autoimmunity Clin Immunol 108 2003 73
30. N. Nishimoto, and T. Kishimoto Interleukin-6: From bench to bedside Nat Clin Pract Rheumatol 2 2006 619
31. D.G. Remick, G.R. Bolgos, and J. Siddiqui Six at six: Interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days Shock 17 2002 463
32. S. Oda, H. Hirasawa, and H. Shiga Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis Cytokine 21 2005 169
33. P. Damas, D. Ledoux, and M. Nys Cytokine serum level during severe sepsis in human IL-6 as a marker of severity Ann Surg 215 1992 356
34. H. Ito, M. Takazoe, and Y. Fukuda A pilot randomized trial of human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease Gastroenterology 126 2004 989